Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis

Aim To develop a novel noninvasive test using an artificial intelligence (AI)/neural network (NN) system (named Fibro‐Scope) to determine the fibrosis stage in nonalcoholic steatohepatitis (NASH). Methods Three hundred twenty‐four and 110 patients with histologically diagnosed nonalcoholic fatty liver disease (NAFLD) were enrolled for training and validation studies, respectively. Two independent pathologists histologically diagnosed patients...